176
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Interaction of cigarette smoke condensate and some of its components with chlorpromazine toxicity on Saccharomyces cerevisiae

, , , , & ORCID Icon
Pages 77-87 | Received 30 Apr 2019, Accepted 04 Aug 2019, Published online: 13 Sep 2019

References

  • Abernathy, C.O., Lukacs, L., and Zimmerman, H.J., 1977. Adverse effects of chlorpromazine metabolites on isolated hepatocytes. Experimental Biology and Medicine, 155(4), 474–478.
  • Alexander, L.E.C., Shin, S., and Hwang, J.H., 2015. Inflammatory diseases of the lung induced by conventional cigarette smoke: a review. Chest, 148, 1307–1322.
  • Anthérieu, S., et al., 2013. Oxidative stress plays a major role in chlorpromazine‐induced cholestasis in human HepaRG cells. Hepatology, 57(4), 1518–1529.
  • Baker, J.R., et al., 2001. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples1. Biochemical Pharmacology, 62(6), 713–721.
  • Barnes, M., et al., 2006. Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Australian and New Zealand Journal of Psychiatry, 40, 575–580.
  • Benowitz, N.L., 2010. Nicotine addiction. The New England Journal of Medicine, 362(24), 2295–2303.
  • Bijnsdorp, I.V., Giovannetti, E., and Peters, G.J., 2011. Analysis of drug interactions. In: Cancer cell culture, Berlin, Germany: Springer, 421–434.
  • Botstein, D., and Fink, G.R., 2011. Yeast: an experimental organism for 21st Century biology. Genetics, 189(3), 695–704.
  • Buchweitz, J.P., et al., 2002. Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? Journal of Pharmacology and Experimental Therapeutics, 300(2), 460–467.
  • Bylund, D.B., 1981. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. Journal of Pharmacology and Experimental Therapeutics, 217(1), 81–86.
  • Caldara, M., et al., 2017. Editor’s highlight: off-target effects of neuroleptics and antidepressants on saccharomyces cerevisiae. Toxicological Sciences, 156, 538–548.
  • Chang, T.K., et al., 2003. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicological Sciences, 71(1), 11–19.
  • Chang, Y.C., et al., 2002. Mechanisms of cytotoxicity of nicotine in human periodontal ligament fibroblast cultures in vitro. Journal of Periodontal Research, 37(4), 279–285.
  • Chen, L., et al., 2011. Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free Radical Biology and Medicine, 50(5), 624–632.
  • Chetty, M., Miller, R., and Moodley, S., 1994. Smoking and body weight influence the clearance of chlorpromazine. European Journal of Clinical Pharmacology, 46(6), 523–526.
  • Chou, T.-C., 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews, 58(3), 621–681.
  • Chou, T.-C., 2010. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Research, 70, 440–444.
  • De Abajo, F.J., et al., 2004. Acute and clinically relevant drug‐induced liver injury: a population based case‐control study. British Journal of Clinical Pharmacology, 58(1), 71–80.
  • De Filippi, L., et al., 2007. Membrane stress is coupled to a rapid translational control of gene expression in chlorpromazine-treated cells. Current Genetics, 52(3–4), 171–185.
  • de Souza Oliveira, R.P., et al., 2012. Response of Saccharomyces cerevisiae to cadmium and nickel stress: the use of the sugar cane vinasse as a potential mitigator. Biological Trace Element Research, 145(1), 71–80.
  • Dejanović, B., et al., 2016. Oxidative stress induced by chlorpromazine in patients treated and acutely poisoned with the drug. Vojnosanitetski Pregled, 73, 312–317.
  • Desai, H.D., Seabolt, J., and Jann, M.W., 2001. Smoking in patients receiving psychotropic medications. CNS Drugs, 15(6), 469–494.
  • Dudley, K., Liu, X., and De Haan, S., 2017. Chlorpromazine dose for people with schizophrenia. Cochrane Database of Systematic Reviews, 4, 491–492.
  • Ebert, B., Seidel, A., and Lampen, A., 2005. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis, 26(10), 1754–1763.
  • Eldridge, A., et al., 2015. Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products. Regulatory Toxicology and Pharmacology, 71(3), 409–427.
  • Elmorsy, E., et al., 2017. The role of oxidative stress in antipsychotics induced ovarian toxicity. Toxicology in Vitro, 44, 190–195.
  • Estruch, F., 2000. Stress-controlled transcription factors, stress-induced genes and stress tolerance in budding yeast. FEMS Microbiology Reviews, 24(4), 469–486.
  • Ezzati, M., et al., 2005. Role of smoking in global and regional cardiovascular mortality. Circulation, 112(4), 489–497.
  • Faux, S.P., et al., 2009. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers, 14(Sup1), 90–96.
  • Flanagan, R.J., and Dunk, L., 2008. Haematological toxicity of drugs used in psychiatry. Human Psychopharmacology: Clinical and Experimental, 23(S1), S27–S41.
  • Fleischmann, R., Remmer, H., and Stärz, U., 1986. Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking. European Journal of Clinical Pharmacology, 30(4), 475–480.
  • Gao, S., et al., 2005. Transcriptional and posttranscriptional inhibition of lysyl oxidase expression by cigarette smoke condensate in cultured rat fetal lung fibroblasts. Toxicological Sciences, 87(1), 197–203.
  • Gasch, A.P., et al., 2000. Genomic expression programs in the response of yeast cells to environmental changes. Molecular Biology of the Cell, 11(12), 4241–4257.
  • Giacomini, K.M., et al., 2010. Membrane transporters in drug development. Nature Reviews Drug Discovery, 9(3), 215.
  • Hecht, S.S., 2002. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. The Lancet Oncology, 3(8), 461–469.
  • Horikawa, M., et al., 2003. Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metabolism and Pharmacokinetics, 18(1), 16–22.
  • John, L., et al., 2005. Cigarette smoke extract induces changes in growth and gene expression of Saccharomyces cerevisiae. Biochemical and Biophysical Research Communications, 338(3), 1578–1586.
  • Johnson, M.D., et al., 2009. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiology Biomarkers and Prevention, 18(12), 3263–3304.
  • Kitamura, M., and Kasai, A., 2007. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Letters, 252(2), 184–194.
  • Kolaczkowski, M., Michalak, K., and Motohashi, N., 2003. Phenothiazines as potent modulators of yeast multidrug resistance. International Journal of Antimicrobial Agents, 22(3), 279–283.
  • Kroon, L.A., 2007. Drug interactions with smoking. American Journal of Health-System Pharmacy, 64(18), 1917–1921.
  • Kuge, S., Jones, N., and Nomoto, A., 1997. Regulation of yAP-1 nuclear localization in response to oxidative stress. The EMBO Journal, 16(7), 1710–1720.
  • Le Vee, M., et al., 2015. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract. PLoS One, 10(3), e0121232.
  • Li, X., 2016. In vitro toxicity testing of cigarette smoke based on the air-liquid interface exposure: A review. Toxicology in Vitro, 36, 105–113.
  • Milionis, H.J., Rizos, E., and Mikhailidis, D.P., 2001. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology, 52(9), 575–587.
  • Miller, L.G., 1989. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clinical Pharmacokinetics, 17(2), 90–108.
  • Müller, T., and Gebel, S., 1998. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis, 19(5), 797–801.
  • Muthukumar, K., and Nachiappan, V., 2010. Cadmium-Induced Oxidative Stress in Saccharomyces cerevisiae. Indian Journal of Biochemistry and Biophysics, 47, 383–387.
  • Muthukumaran, S., et al., 2008. Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology, 243(1–2), 207–215.
  • Nagaraj, N.S., et al., 2006. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicology Letters, 165(2), 182–194.
  • Okazaki, S., et al., 2007. Multistep disulfide bond formation in Yap1 is required for sensing and transduction of H 2 O 2 stress signal. Molecular Cell, 27(4), 675–688.
  • Pan, W.-C., et al., 2009. Suppressive effect of tobacco smoke extracts on oral P-glycoprotein function and its impact in smoke-induced insult to oral epidermal cells. Toxicology Letters, 185(2), 116–123.
  • Pantuck, E.J., et al., 1982. Cigarette smoking and chlorpromazine disposition and actions. Clinical Pharmacology and Therapeutics, 31, 533–538.
  • Pappas, R., et al., 2006. Cadmium, lead, and thallium in mainstream tobacco smoke particulate. Food and Chemical Toxicology, 44(5), 714–723.
  • Parmentier, C., et al., 2013. Transcriptomic hepatotoxicity signature of chlorpromazine after short and long-term exposure in primary human sandwich cultures. Drug Metabolism and Disposition, 41(10), 1835.
  • Petrenko, N., et al., 2013. Noise and interlocking signaling pathways promote distinct transcription factor dynamics in response to different stresses. Molecular Biology of the Cell, 24(12), 2045–2057.
  • Pillai, A., et al., 2007. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research, 41(5), 372–386.
  • Raitt, D.C., et al., 2000. The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsf1 in vivo and is required for the induction of heat shock genes by oxidative stress. Molecular Biology of the Cell, 11(7), 2335–2347.
  • Roberto, A., and Caetano, P.P., 2005. A High-Throughput Screening Method for General Cytotoxicity Part I Chemical Toxicity. Lusophone Journal of Health Sciences and Technologies, 2, 95–100.
  • Russell, M., et al., 1980. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. BMJ, 280(6219), 972–976.
  • S van Leeuwen, J., PE Vermeulen, N., and Chris Vos, J., 2012. Yeast as a humanized model organism for biotransformation-related toxicity. Current Drug Metabolism, 13, 1464–1475.
  • Saffi, J., et al., 2006. Antioxidant activity of L-ascorbic acid in wild-type and superoxide dismutase deficient strains of Saccharomyces cerevisiae. Redox Report, 11(4), 179–184.
  • Sasaki, J., 2013. Compounds in tobacco smoke and pathogenesis of the diseases. Nihon rinsho. Japanese Journal of Clinical Medicine, 71(3), 383–389.
  • Sasco, A., Secretan, M., and Straif, K., 2004. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer, 45, S3–S9.
  • Sayyed, K., et al., 2016. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology, 363, 58–71.
  • Sayyed, K., et al., 2017. Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate. Toxicology in Vitro, 44, 27–35.
  • Sayyed, K., et al., 2018. Cigarette smoke condensate alters Saccharomyces cerevisiae efflux transporter mRNA and activity and increases caffeine toxicity. Toxicology, 409, 129–136.
  • Sayyed, K., et al., 2019. Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines. Toxicology in Vitro, 54, 10–22.
  • Schrenk, D., et al., 1998. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. European Journal of Clinical Pharmacology, 53(5), 361–367.
  • Sharma, S., Kaur, H., and Khuller, G., 2001. Cell cycle effects of the phenothiazines: trifluoperazine and chlorpromazine in Candida albicans. FEMS Microbiology Letters, 199(2), 185–190.
  • Sohn, H.S., et al., 2015. Evidence supporting the need for considering the effects of smoking on drug disposition and effectiveness in medication practices: a systematic narrative review. International Journal of Clinical Pharmacology and Therapeutics, 53(08), 621–634.
  • Stimmel, G., and Falloon, I., 1983. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report. The Journal of Clinical Psychiatry, 44(11), 420–422.
  • Swett, C., 1974. Drowsiness due to chlorpromazine in relation to cigarette smoking: a report from the Boston Collaborative Drug Surveillance Program. Archives of General Psychiatry, 31(2), 211–213.
  • Swett, C., et al., 1977. Hypotension due to chlorpromazine: relation to cigarette smoking, blood pressure, and dosage. Archives of General Psychiatry, 34(6), 661–663.
  • Święciło, A., 2016. Cross-stress resistance in Saccharomyces cerevisiae yeast-new insight into an old phenomenon. Cell Stress and Chaperones, 21(2), 187–200.
  • Talhout, R., et al., 2011. Hazardous compounds in tobacco smoke. International Journal of Environmental Research and Public Health, 8(2), 613–628.
  • Tavoloni, N., and Boyer, J.L., 1980. Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver. Journal of Pharmacology and Experimental Therapeutics, 214(2), 269–274.
  • Tenreiro, S., et al., 2013. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. Journal of Neurochemistry, 127(4), 438–452.
  • Tsang, C.K., et al., 2014. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nature Communications, 5(1), 3446.
  • Uetrecht, J., 2003. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. Drug Discovery Today, 8(18), 832–837.
  • Ulrich, R.G., 2007. Idiosyncratic toxicity: a convergence of risk factors. Annual Review of Medicine, 58, 17–34.
  • van der Deen, M., et al., 2007. Cigarette smoke extract affects functional activity of MRP1 in bronchial epithelial cells. Journal of Biochemical and Molecular Toxicology, 21(5), 243–251.
  • Van der Vaart, H., et al., 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax, 59(8), 713–721.
  • van Leeuwen, J.S., Vermeulen, N.P., and Vos, J.C., 2011. Involvement of the pleiotropic drug resistance response, protein kinase c signaling, and altered zinc homeostasis in resistance of saccharomyces cerevisiae to diclofenac. Applied and Environmental Microbiology, 77(17), 5973–5980.
  • Vitale, R.G., et al., 2007. Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes. Mycoses, 50(4), 270–276.
  • Wang, K., et al., 2002. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. The Journal of Toxicological Sciences, 27(3), 229–237.
  • Wang, X., et al., 2017. Reactive oxygen species and Ca2+ are involved in cadmium-induced cell killing in yeast cells. Canadian Journal of Microbiology, 63(2), 153–159.
  • Washio, I., et al., 2011. Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes. Drug Metabolism and Disposition, 39(1), 1–3.
  • Watson, R., et al., 1988. A proposed mechanism for chlorpromazine jaundice—defective hepatic sulphoxidation combined with rapid hydroxylation. Journal of Hepatology, 7(1), 72–78.
  • WHO. 2008. WHO report on the global tobacco epidemic, 2008: the MPOWER package. World Health Organization.
  • Wójcikowski, J., Boksa, J., and Daniel, W.A., 2010. Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver—A comparison with other phenothiazines. Biochemical Pharmacology, 80(8), 1252–1259.
  • Xu, S., et al., 2010. Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. American Journal of Physiology-Gastrointestinal and Liver Physiology, 299(1), G126.
  • Yang, C.S., et al., 2008. Inhibition of cadmium‐induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. Journal of Cellular Biochemistry, 103(3), 825–834.
  • Yarahmadi, A., Zal, F., and Bolouki, A., 2017. Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells. Toxicology Mechanisms and Methods, 27(8), 609–614.
  • Yeung, P.-F., et al., 1993. Pharmacokinetics of chlorpromazine and key metabolites. European Journal of Clinical Pharmacology, 45(6), 563–569.
  • Yoshii, K., et al., 2000. Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Life Sciences, 67(2), 175–184.
  • Zhao, L., Wientjes, M.G., and Au, J.L., 2004. Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clinical Cancer Research, 10(23), 7994–8004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.